report-bg

Broncho Therapy and Treatment Market Segmentation by Disease (Asthma, Bronchitis, and Others); by Medication (Bronchodilators, Anti-inflammatory, Antibiotic, and Others); and by End-User (Hospitals, Specialty Clinics, and Others) – Global Demand Analysis & Opportunity Outlook 2030

Buy Now Report ID: 3708 | Published Date: Feb 07, 2023

Global Broncho Therapy and Treatment Market Regional Synopsis

On the basis of geographical analysis, the global broncho therapy and treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Asia Pacific region witnessed or is estimated to witness noteworthy growth over the forecast period on the back of high pollution level in the APAC region, along with rising awareness amongst the people regarding diagnosis and treatment of diseases. Moreover, increasing incidences of chronic bronchitis in the region is projected to boost the regional market growth.

The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the high incidences of asthma in the region. According to the data by the Center for Disease Control and Prevention (CDC), 25,131,132 cases of asthma were reported in the United States, in 2019, out of which, 5,104,410 were children below the age of 18 years.

Broncho Therapy and Treatment Market

Get more information on this reportDownload Sample PDF

The global broncho therapy and treatment market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth Market Players Analysis & Opportunity Outlook


RN
Broncho Therapy and Treatment Market
Get more information on this report: Request Free Sample PDF

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.


Market Segmentation

Market-Growth-Drivers

Our in-depth analysis of the global broncho therapy and treatment market includes the following segments:

By Disease

  • Asthma
  • Bronchitis
  • Others

By Medications

  • Bronchodilators
  • Anti-inflammatory
  • Antibiotic
  • Others

By End-User

  • Hospitals
  • Specialty Clinics
  • Others

Growth Drivers

  • Increasing Cases of Asthma and Bronchitis
  • Rising Investment for Improving Healthcare Facilities

Challenges

  • Competition from Over-the-Counter Medications
  • Lack of Awareness in Low-Income Regions


Per Capita Healthcare
Get more information on this report: Request Free Sample PDF

Top Featured Companies Dominating the Market

top-features-companies
    • Abbott Laboratories
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Teva Pharmaceutical Industries Ltd.
    • Mylan N.V.
    • Sanofi S.A.
    • GlaxoSmithKline plc
    • Merck & Co., Inc.
    • Otsuka Pharmaceutical Co., Ltd.,
    • Novartis International AG
    • Eli Lilly and Company
    • Hindustan Antibiotics Limited

In-the-news

In The News

  • February, 2021: Koninklijke Philips N.V. announced the acquisition of BioTelemetry, Inc., a leading provider of remote diagnostics and monitoring systems, to widen the scope for early diagnosis.
  • June, 2020: GlaxoSmithKline plc and Vir Biotechnology, Inc. to conduct the Phase 3 trial of sotrovimab antimicrobial drug.

preview-analysis

Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.


Author Credits:  Radhika Gupta, Shivam Bhutani


Key Questions Answered in the Report

1) What are the major factors driving the growth of the broncho therapy and treatment market?

Ans: The growing incidences of asthma and other respiratory diseases is estimated to boost the market growth.

2) What would be the CAGR of broncho therapy and treatment market over the forecast period?

Ans: The market is anticipated to attain a significant CAGR over the forecast period, i.e., 2022 – 2030.

3) What are the challenges affecting the broncho therapy and treatment market growth?

Ans: The lack of awareness in middle, and low-income region is estimated to hamper the market growth.

4) Which region will provide more business opportunities for growth of broncho therapy and treatment market in future?

Ans: The market in the North America region is anticipated to provide more business opportunities owing to the high prevalence of asthma in the region.

5) Who are the major players dominating the broncho therapy and treatment market?

Ans: The major players in the market are Mylan N.V., Sanofi S.A., GlaxoSmithKline plc, Merck & Co., Inc., Otsuka Pharmaceutical Co., Ltd, Abbott Laboratories, Eli Lilly and Company, and others.

6) How are the company profiles selected?

Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.

7) What are the segments in the broncho therapy and treatment market?

Ans: The market is segmented by disease, medication, end-user, and by region.

8) Which segment captures the largest market size in end-user segment in the broncho therapy and treatment market?

Ans: The hospital segment is anticipated to hold largest market size over the forecast period and display significant growth opportunities.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

 Request Free Sample Copy